Cargando…

Effects of prolonging administration gonadotropin on unexpectedly poor ovarian responders undergoing in vitro fertilization

BACKGROUND: There are still some patients who show poor response to ovarian stimulation prior to evidence of normal ovarian reserve in vitro fertilization. However, there are few studies about how to treat the unexpectedly ovarian poor responder in vitro fertilization. The main aim of this study eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Zhaolian, Cheng, Xianxia, Li, Huirong, Cao, Yunxia, Cong, Lin, Zhou, Ping, Li, Jun
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Methodology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845138/ https://www.ncbi.nlm.nih.gov/pubmed/20236519 http://dx.doi.org/10.1186/1477-7827-8-26

Ejemplares similares

Efficacy of luteal estrogen administration and an early follicular Gonadotropin-releasing hormone antagonist priming protocol in poor responders undergoing in vitro fertilization
por: Lee, Hwajeong, et al.
Publicado: (2018)

Type and dose of gonadotropins in poor ovarian responders: does it matter?
por: Boudry, Liese, et al.
Publicado: (2021)

Does daily co administration of gonadotropins and letrozole during the ovarian stimulation improve IVF outcome for poor and sub optimal responders?
por: Shapira, Moran, et al.
Publicado: (2020)

Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamide
por: Lemos, Claudia NCD, et al.
Publicado: (2010)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
por: Conforti, Alessandro, et al.
Publicado: (2019)

Perifollicular Vascularity in Poor Ovarian Responders in In vitro Fertilization Cycles
por: Majeed, Asifa, et al.
Publicado: (2018)

The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders
por: Vural, Fisun, et al.
Publicado: (2015)

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
por: Takeuchi, Kazuhiro, et al.
Publicado: (2023)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
por: Chen, Qiuju, et al.
Publicado: (2019)

The earlier the initiation of gonadotropin in poor responders in luteal phase stimulation protocols, the better
por: Huang, Jia, et al.
Publicado: (2022)

Comment on “The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders”
por: Orvieto, Raoul
Publicado: (2015)

Gonadotropins in Keratoconus: The Unexpected Suspects
por: Karamichos, Dimitrios, et al.
Publicado: (2019)

Follicular flushing increases the number of oocytes retrieved in poor ovarian responders undergoing in vitro fertilization: a retrospective cohort study
por: Xiao, Yu, et al.
Publicado: (2018)

Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection
por: Boza, Aysen, et al.
Publicado: (2016)

The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial
por: Mohammadi, Sahar, et al.
Publicado: (2021)

Gonadotropin versus Follicle-Stimulating Hormone for Ovarian Response in Patients Undergoing in vitro Fertilization: A Retrospective Cohort Comparison
por: Ji, Zhisong, et al.
Publicado: (2019)

Effect of pretreatment with transdermal testosterone on poor ovarian responders undergoing IVF/ICSI: A meta-analysis
por: LUO, SHAN, et al.
Publicado: (2014)

Patients undergoing elective and oncofertility preservation respond similarly to controlled ovarian stimulation for fertility preservation
por: Kira, Ariane Tieko Frare, et al.
Publicado: (2022)

Live births from in vitro fertilization-embryo transfer following the administration of gonadotropin-releasing hormone agonist without gonadotropins: Two case reports
por: Li, Mai, et al.
Publicado: (2023)

Ovarian stimulation modalities in poor responders
por: ÖZKAN, Zehra Sema
Publicado: (2019)

Treatment modalities for poor ovarian responders
por: Di Guardo, Federica, et al.
Publicado: (2023)

Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial
por: Zhang, Huanhuan, et al.
Publicado: (2016)

Different gonadotropin releasing hormone agonist doses for the final oocyte maturation in high-responder patients undergoing in vitro fertilization/intra-cytoplasmic sperm injection
por: Pabuccu, Emre Goksan, et al.
Publicado: (2015)

Luteal phase ovarian stimulation for poor ovarian responders
por: Zhang, Wei, et al.
Publicado: (2018)

Ovarian Follicular Growth through Intermittent Vaginal Gonadotropin Administration in Diminished Ovarian Reserve Women
por: Hsu, Chao-Chin, et al.
Publicado: (2022)

The incidence of unexpected poor ovarian response in Chinese young women
por: Zhuang, Jing, et al.
Publicado: (2019)

Cumulative Live Birth Rate and Cost-Effectiveness Analysis of Gonadotropin Releasing Hormone-Antagonist Protocol and Multiple Minimal Ovarian Stimulation in Poor Responders
por: Liu, Yuan, et al.
Publicado: (2021)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
por: Hong, Yeon Hee, et al.
Publicado: (2022)

Natural Cycle Results in Lower Implantation Failure than Ovarian Stimulation in Advanced-Age Poor Responders Undergoing IVF: Fertility Outcomes from 585 Patients
por: De Marco, Maria Paola, et al.
Publicado: (2021)

Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders
por: Karacan, Meric, et al.
Publicado: (2017)

Ovarian Hyper-Response to Administration of an GnRH-Agonist Without Gonadotropins
por: Park, Hyun Tae, et al.
Publicado: (2011)

“Short agonist stop” protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study
por: Mauries, Charlotte, et al.
Publicado: (2022)

Predicting IVF outcome in poor ovarian responders
por: Lebovitz, Oshrit, et al.
Publicado: (2022)

Poor responders in in vitro fertilization (IVF) therapy: the challenge continues
por: Oehninger, S.
Publicado: (2011)

Mutation analysis of the WNT4 gene in Han Chinese women with premature ovarian failure
por: Chen, Beili, et al.
Publicado: (2011)

The role of Erzhi Tiangui formula in expected poor ovarian responders undergoing in vitro fertilization-embryo transfer: A multicenter, randomized, double-blind, placebo-controlled trial
por: Han, Qiao-Song, et al.
Publicado: (2023)

Comparison of corifollitropin alfa and daily recombinant follicle-stimulating hormone in poor responder patients undergoing in vitro fertilization cycles
por: Akarsu, Süleyman, et al.
Publicado: (2017)

Hormonal induction of spawning in 4 species of frogs by coinjection with a gonadotropin-releasing hormone agonist and a dopamine antagonist
por: Trudeau, Vance L, et al.
Publicado: (2010)

Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria
por: Li, Fei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vbcsgf68kgg82t511dags7j5qd